Annual Report of the Company for the financial year 2024-25 is attached herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has submitted its Annual Report for the financial year 2024-25 to BSE as a regulatory filing. The actual report, which would contain detailed financials, management discussion, and auditor's report, is attached with the announcement. No specific financial highlights or numbers are mentioned in the headline. Shareholders and investors can review the full document to assess the company's annual performance. This is a routine compliance filing required under listing regulations.
This is a routine regulatory submission with no direct impact on stock price. However, the detailed annual report may reveal key financial trends, revenue growth, profitability, and future strategy that could influence investor sentiment upon review.